The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).

The tablet formulation can either be swallowed whole or dispersed in a teaspoon of filtered (non-chlorinated) water.

If you're looking for a larger canvas for reading, sketching, gaming, or just about anything else, you're likely much better off going with a tablet. This lets your smartphone keep doing what it ...

Tablets may not be the trendiest devices in 2025, but they remain excellent tools for streaming movies, playing games, or getting work done on the go. While the best iPads continue to dominate the ...

Cholesterol, a lipid naturally processed by the liver, is an essential component of the human body. Yet, it has a bad ...

Patients receiving double-drug hypolipidaemic treatment should be carefully monitored to avoid possible severe complications.

Pitavastatin is a novel statin that induces plaque regression and is non-inferior to atorvastatin and, on some measures, superior to simvastatin and to pravastatin in the elderly. Pitavastatin ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Though information on a potential sequel is scarce, there are scattered morsels of ...

Discover why combining simvastatin and rifaximin does not offer a clinically meaningful advantage in preventing severe ...

It entered the Android and Windows tablet market in 2011, began selling Android smartphones in 2012, and acquired Motorola Mobility from Google in 2014. The company has also launched an online-only ...

It released its first Android smartphone in 2009, and can be credited with the launch of the first Android tablet back in 2010. The company is among the biggest players in the smartphone market in the ...